143 related articles for article (PubMed ID: 25939167)
41. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: existence of a paracrine system for 1,25 dihydroxycholecalciferol.
Rizk-Rabin M; Zineb R; Zhor B; Michèle G; Jana P
J Cell Physiol; 1994 Apr; 159(1):131-41. PubMed ID: 8138581
[TBL] [Abstract][Full Text] [Related]
43. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
44. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
Sørensen S; Sølvsten H; Politi Y; Kragballe K
Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
[TBL] [Abstract][Full Text] [Related]
45. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
46. 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro.
Cornet A; Baudet C; Neveu I; Baron-Van Evercooren A; Brachet P; Naveilhan P
J Neurosci Res; 1998 Sep; 53(6):742-6. PubMed ID: 9753201
[TBL] [Abstract][Full Text] [Related]
47. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
48. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
49. Ultraviolet B suppresses vitamin D receptor gene expression in keratinocytes.
Courtois SJ; Segaert S; Degreef H; Bouillon R; Garmyn M
Biochem Biophys Res Commun; 1998 May; 246(1):64-9. PubMed ID: 9600069
[TBL] [Abstract][Full Text] [Related]
50. All-trans retinoic acid inhibits binding of 1,25-dihydroxy-vitamin D3 to the vitamin D receptor in cultured human keratinocytes.
Fogh K; Sølvsten H; Jøhnke H; Kragballe K
Exp Dermatol; 1996 Feb; 5(1):24-7. PubMed ID: 8624608
[TBL] [Abstract][Full Text] [Related]
51. Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions.
McLane JA; Katz M; Abdelkader N
In Vitro Cell Dev Biol; 1990 Apr; 26(4):379-87. PubMed ID: 2345124
[TBL] [Abstract][Full Text] [Related]
52. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
Chen TC; Holick MF
Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
[TBL] [Abstract][Full Text] [Related]
53. Inhibitory effects of 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid on parathyroid hormone-related protein expression by oral cancer cells (HSC-3).
Abe M; Akeno N; Ohida S; Horiuchi N
J Endocrinol; 1998 Feb; 156(2):349-57. PubMed ID: 9518882
[TBL] [Abstract][Full Text] [Related]
54. Stimulation versus inhibition of keratinocyte growth by 1,25-Dihydroxyvitamin D3: dependence on cell culture conditions.
Gniadecki R
J Invest Dermatol; 1996 Mar; 106(3):510-6. PubMed ID: 8648185
[TBL] [Abstract][Full Text] [Related]
55. Regulation of cell growth, c-myc mRNA, and 1,25-(OH)2 vitamin D3 receptor in C3H/10T1/2 mouse embryo fibroblasts by calcipotriol and 1,25-(OH)2 vitamin D3.
Trydal T; Lillehaug JR; Aksnes L; Aarskog D
Acta Endocrinol (Copenh); 1992 Jan; 126(1):75-9. PubMed ID: 1310564
[TBL] [Abstract][Full Text] [Related]
56. 1,25-Dihydroxyvitamin D-3 destabilizes c-myc mRNA in HL-60 leukemic cells.
Mangasarian K; Mellon WS
Biochim Biophys Acta; 1993 Feb; 1172(1-2):55-63. PubMed ID: 8439572
[TBL] [Abstract][Full Text] [Related]
57. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
58. Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes.
Kragballe K; Wildfang IL
Arch Dermatol Res; 1990; 282(3):164-7. PubMed ID: 2164359
[TBL] [Abstract][Full Text] [Related]
59. 1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line.
Biskobing DM; Rubin J
Endocrinology; 1993 Feb; 132(2):862-6. PubMed ID: 8425498
[TBL] [Abstract][Full Text] [Related]
60. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
